Shopping Cart 0
Cart Subtotal
USD 0

Pharmaceutical Continuous Manufacturing Market by Product (Integrated Continuous Systems, Semicontinuous Systems, and Control & Software), Application (Final Drug Product Manufacturing and API Manufacturing), and End User (Pharmaceutical Companies, Contract Manufacturing Organizations, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 5370

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 8995

Details

The global pharmaceutical continuous manufacturing market was valued at USD 393 million in 2018, and is projected to reach USD 855 million by 2026, registering a CAGR of 10.2% from 2019 to 2026.

Continuous manufacturing is advanced manufacturing approach that is performed by employing end-to-end integration of manufacturing subprocesses with a significant level of control strategies.

The growth of the global pharmaceutical continuous manufacturing market is anticipated to be driven by increase in adoption of continuous manufacturing systems over existing drug manufacturing process, technological advancements in CM systems, and rise in awareness of continuous manufacturing systems in developing regions are anticipated to significantly boost the growth of the pharmaceutical continuous manufacturing market during the forecast period. Continuous pharmaceutical manufacturing system offers advantages such as reduced fluctuation in production, improved yields, lower cost of operation & equipment further augment the market growth.

Moreover, initiatives taken by the Food and drug Administration (FDA) for promoting the use of pharmaceutical continuous manufacturing systems and advantage of CM systems over the batch manufacturing are the major factors to boost the growth of pharmaceutical continuous manufacturing market. However, higher cost of pharmaceutical continuous manufacturing systems impede the market growth.

Moreover, the CM process is more time-efficient, reduces energy needs, helps to increase productivity, and minimizes overall waste, which are expected to offer lucrative opportunity for the pharmaceutical continuous manufacturing market during the forecast period.

The global pharmaceutical continuous manufacturing market is segmented into product, application, end user, and region. On the basis of product, the market is classified into integrated continuous systems, semicontinuous systems, and control & software. By application, it is divided into final drug product manufacturing and API manufacturing. Depending on end user, it is categorized into pharmaceutical companies, contract manufacturing organizations, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of four major regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Product

o Integrated Continuous Systems

o Semicontinuous Systems

o Control & Software

Application Type

o Final Drug Product Manufacturing

o API Manufacturing

End User

o Pharmaceutical Companies

o Contract Manufacturing Organizations

o Others

By Region

North America

o U.S.

o Canada

o Mexico

Europe

o Germany

o France

o UK

o Italy

o Rest of Europe

Asia-Pacific

o Japan

o China

o India

o Rest of Asia-Pacific

LAMEA

o Brazil

o Saudi Arabia

o South Africa

o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Bosch Packaging Technology

Coperion GmbH

GEA Group AG

Gebruder Lodige Maschinenbau GmbH

Glatt GmbH

Hosokawa Micron Corporation

Korsch AG

L.B. Bohle Maschinen + Verfahren GmbH

Munson Machinery Company, Inc.

Thermo Fisher Scientific Inc.

READ MORE

Table Of Content

Scope

Chapter 1: Introduction

1.1. Report Description

1.2. Key Benefits For Stakeholders

1.3. Key Market Segments

1.3.1. List of Key Players Profiled In The Report

1.4. Research Methodology

1.4.1. Secondary Research

1.4.2. Primary Research

1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

2.1. Key Findings of The Study

2.2. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope

3.2. Key Findings

3.2.1. Top Investment Pockets

3.2.2. Market Player Positioning, 2018

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Increase In Government Support For Continuous Manufacturing Adoption

3.3.1.2. Advantages offered By Continuous Manufacturing Systems

3.3.1.3. Surge In Adoption of Pharmaceutical Continuous Manufacturing Systems

3.3.2. Restraint

3.3.2.1. Poor Demand In Under Developed Countries

3.3.3. Opportunities

3.3.3.1. Growth Opportunities In Emerging Markets

3.3.4. Impact Analysis

Chapter 4: Pharmaceutical Continuous Manufacturing Market, By Product

4.1. Overview

4.1.1. Market Size And Forecast

4.2. Integrated Continuous Systems

4.2.1. Key Market Trends And Opportunities

4.2.2. Market Size And Forecast, By Region

4.2.3. Market Analysis, By Country

4.3. Semi-Continuous Systems

4.3.1. Key Market Trends And Opportunities

4.3.2. Market Size And Forecast, By Region

4.3.3. Market Analysis, By Country

4.4. Control & Software

4.4.1. Key Market Trends And Opportunities

4.4.2. Market Size And Forecast, By Region

4.4.3. Market Analysis, By Country

Chapter 5: Pharmaceutical Continuous Manufacturing Market, By Application

5.1. Overview

5.1.1. Market Size And Forecast

5.2. Final Drug Product Manufacturing

5.2.1. Market Size And Forecast

5.2.2. Market Analysis, By Country

5.3. Api Manufacturing

5.3.1. Market Size And Forecast

5.3.2. Market Analysis, By Country

Chapter 6: Pharmaceutical Continuous Manufacturing Market, By End User

6.1. Overview

6.1.1. Market Size And Forecast

6.2. Pharmaceutical Companies

6.2.1. Market Size And Forecast

6.2.2. Market Analysis, By Country

6.3. Contract Manufacturing Organizations

6.3.1. Market Size And Forecast

6.3.2. Market Analysis, By Country

6.4. Others

6.4.1. Market Size And Forecast

6.4.2. Market Analysis, By Country

Chapter 7: Pharmaceutical Continuous Manufacturing Market, By Region

7.1. Overview

7.1.1. Market Size And Forecast

7.2. North America

7.2.1. Key Market Trends, Growth Factors, And Opportunities

7.2.2. Market Size And Forecast, By Country

7.2.2.1. U.S.

7.2.2.1.1. U.S. Pharmaceutical Continuous Manufacturing Market, By Product

7.2.2.1.2. U.S. Pharmaceutical Continuous Manufacturing Market, By Application

7.2.2.1.3. U.S. Pharmaceutical Continuous Manufacturing Market, By End User

7.2.2.2. Canada

7.2.2.2.1. Canada Pharmaceutical Continuous Manufacturing Market, By Product

7.2.2.2.2. Canada Pharmaceutical Continuous Manufacturing Market, By Application

7.2.2.2.3. Canada Pharmaceutical Continuous Manufacturing Market, By End User

7.2.2.3. Mexico

7.2.2.3.1. Mexico Pharmaceutical Continuous Manufacturing Market, By Product

7.2.2.3.2. Mexico Pharmaceutical Continuous Manufacturing Market, By Application

7.2.2.3.3. Mexico Pharmaceutical Continuous Manufacturing Market, By End User

7.2.3. North America Market Size And Forecast, By Product

7.2.4. North America Market Size And Forecast, By Application

7.2.5. North America Market Size And Forecast, By End User

7.3. Europe

7.3.1. Key Market Trends, Growth Factors, And Opportunities

7.3.2. Market Size And Forecast, By Country

7.3.2.1. Germany

7.3.2.1.1. Germany Pharmaceutical Continuous Manufacturing Market, By Product

7.3.2.1.2. Germany Pharmaceutical Continuous Manufacturing Market, By Application

7.3.2.1.3. Germany Pharmaceutical Continuous Manufacturing Market, By End User

7.3.2.2. France

7.3.2.2.1. France Pharmaceutical Continuous Manufacturing Market, By Product

7.3.2.2.2. France Pharmaceutical Continuous Manufacturing Market, By Application

7.3.2.2.3. France Pharmaceutical Continuous Manufacturing Market, By End User

7.3.2.3. Uk

7.3.2.3.1. Uk Pharmaceutical Continuous Manufacturing Market, By Product

7.3.2.3.2. Uk Pharmaceutical Continuous Manufacturing Market, By Application

7.3.2.3.3. Uk Pharmaceutical Continuous Manufacturing Market, By End User

7.3.2.4. Italy

7.3.2.4.1. Italy Pharmaceutical Continuous Manufacturing Market, By Product

7.3.2.4.2. Italy Pharmaceutical Continuous Manufacturing Market, By Application

7.3.2.4.3. Italy Pharmaceutical Continuous Manufacturing Market, By End User

7.3.2.5. Rest of Europe

7.3.2.5.1. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Product

7.3.2.5.2. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Application

7.3.2.5.3. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By End User

7.3.3. Europe Market Size And Forecast, By Product

7.3.4. Europe Market Size And Forecast, By Application

7.3.5. Europe Market Size And Forecast, By End User

7.4. Asia-Pacific

7.4.1. Key Market Trends, Growth Factors, And Opportunities

7.4.2. Market Size And Forecast, By Country

7.4.2.1. Japan

7.4.2.1.1. Japan Pharmaceutical Continuous Manufacturing Market, By Product

7.4.2.1.2. Japan Pharmaceutical Continuous Manufacturing Market, By Application

7.4.2.1.3. Japan Pharmaceutical Continuous Manufacturing Market, By End User

7.4.2.2. China

7.4.2.2.1. China Pharmaceutical Continuous Manufacturing Market, By Product

7.4.2.2.2. China Pharmaceutical Continuous Manufacturing Market, By Application

7.4.2.2.3. China Pharmaceutical Continuous Manufacturing Market, By End User

7.4.2.3. India

7.4.2.3.1. India Pharmaceutical Continuous Manufacturing Market, By Product

7.4.2.3.2. India Pharmaceutical Continuous Manufacturing Market, By Application

7.4.2.3.3. India Pharmaceutical Continuous Manufacturing Market, By End User

7.4.2.4. Rest of Asia-Pacific

7.4.2.4.1. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product

7.4.2.4.2. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application

7.4.2.4.3. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User

7.4.3. Asia-Pacific Market Size And Forecast, By Product

7.4.4. Asia-Pacific Market Size And Forecast, By Application

7.4.5. Asia-Pacific Market Size And Forecast, By End User

7.5. Lamea

7.5.1. Key Market Trends, Growth Factors, And Opportunities

7.5.2. Market Size And Forecast, By Country

7.5.2.1. Brazil

7.5.2.1.1. Brazil Pharmaceutical Continuous Manufacturing Market, By Product

7.5.2.1.2. Brazil Pharmaceutical Continuous Manufacturing Market, By Application

7.5.2.1.3. Brazil Pharmaceutical Continuous Manufacturing Market, By End User

7.5.2.2. South Africa

7.5.2.2.1. South Africa Pharmaceutical Continuous Manufacturing Market, By Product

7.5.2.2.2. South Africa Pharmaceutical Continuous Manufacturing Market, By Application

7.5.2.2.3. South Africa Pharmaceutical Continuous Manufacturing Market, By End User

7.5.2.3. Saudi Arabia

7.5.2.3.1. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Product

7.5.2.3.2. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Application

7.5.2.3.3. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By End User

7.5.2.4. Rest of Lamea

7.5.2.4.1. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Product

7.5.2.4.2. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Application

7.5.2.4.3. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By End User

7.5.3. Lamea Market Size And Forecast, By Product

7.5.4. Lamea Market Size And Forecast, By Application

7.5.5. Lamea Market Size And Forecast, By End User

Chapter 8: Company Profiles

8.1. Coperion Gmbh

8.1.1. Company Overview

8.1.2. Company Snapshot

8.1.3. Operating Business Segments

8.1.4. Product Portfolio

8.1.5. Key Strategic Moves And Developments

8.2. Gea Group Ag

8.2.1. Company Overview

8.2.2. Company Snapshot

8.2.3. Operating Business Segments

8.2.4. Product Portfolio

8.2.5. Business Performance

8.3. Gebruder Lodige Maschinenbau Gmbh

8.3.1. Company Overview

8.3.2. Company Snapshot

8.3.3. Operating Business Segments

8.3.4. Product Portfolio

8.4. Glatt Gmbh

8.4.1. Company Overview

8.4.2. Company Snapshot

8.4.3. Operating Business Segments

8.4.4. Product Portfolio

8.5. Hosokawa Micron Corporation

8.5.1. Company Overview

8.5.2. Company Snapshot

8.5.3. Product Portfolio

8.5.4. Business Performance

8.6. Korsch Ag

8.6.1. Company Overview

8.6.2. Company Snapshot

8.6.3. Operating Business Segments

8.6.4. Product Portfolio

8.7. L.B. Bohle Maschinen + Verfahren Gmbh

8.7.1. Company Overview

8.7.2. Company Snapshot

8.7.3. Operating Business Segments

8.7.4. Product Portfolio

8.8. Munson Machinery Company, Inc.

8.8.1. Company Overview

8.8.2. Company Snapshot

8.8.3. Operating Business Segments

8.8.4. Product Portfolio

8.9. Robert Bosch Packaging Technology Gmbh

8.9.1. Company Overview

8.9.2. Company Snapshot

8.9.3. Operating Business Segments

8.9.4. Product Portfolio

8.9.5. Business Performance

8.10. Thermo Fisher Scientific, Inc.

8.10.1. Company Overview

8.10.2. Company Snapshot

8.10.3. Operating Business Segments

8.10.4. Product Portfolio

8.10.5. Business Performance


List Of Figure

List of Figures

Figure 01. Global Pharmaceutical Continuous Manufacturing Market Segmentation

Figure 02. Top Investment Pockets, 2018

Figure 03. Market Player Positioning, 2018

Figure 04. Impact Analysis

Figure 05. Comparative Analysis of Integrated Continuous Systems Market, By Country, 2018 & 2026 (USD Million)

Figure 06. Comparative Analysis of Semi-Continuous Systems Market, By Country, 2018 & 2026 (USD Million)

Figure 07. Comparative Analysis of Control & Software Market, By Country, 2018 & 2026 (USD Million)

Figure 08. Comparative Analysis of Final Drug Product Manufacturing Market, By Country, 2018 & 2026 (USD Million)

Figure 09. Comparative Analysis of Api Manufacturing Market, By Country, 2018 & 2026 (USD Million)

Figure 10. Comparative Analysis of Pharmaceutical Continuous Manufacturing For Pharmaceutical Companies Market, By Country, 2018 & 2026 (USD Million)

Figure 11. Comparative Analysis Pharmaceutical Continuous Manufacturing Market For Contract Manufacturing Organizations, By Country, 2018 & 2026 (%)

Figure 12. Comparative Analysis of Pharmaceutical Continuous Manufacturing Market For Others, By Country, 2018 & 2026 (%)

Figure 13. Net Sales, 2016-2018 (USD Million)

Figure 14. Gea Group: Net Sales By Segment, 2018 (%)

Figure 15. Gea Group: Net Sales By Region, 2018 (%)

Figure 16. Net Sales, 2016-2018 (USD Million)

Figure 17. Hosokawa: Net Sales By Segment, 2018 (%)

Figure 18. Hosokawa: Net Sales By Geography, 2018 (%)

Figure 19. Net Sales, 2016-2018 (USD Million)

Figure 20. Bosch Group: Net Sales By Segment, 2018 (%)

Figure 21. Bosch Group: Net Sales By Revenue, 2018 (%)

Figure 22. Thermo Fisher Scientific: Revenue, 2016-2018 (USD Million)

Figure 23. Thermo Fisher Scientific: Revenue Share, By Segment, 2018 (%)

Figure 24. Thermo Fisher Scientific: Revenue Share, By Region, 2018 (%)


List Of Table

List of Tables

Table 01. Global Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026 (USD Million)

Table 02. Integrated Continuous Systems Market, By Region, 2018-2026 (USD Million)

Table 03. Semi-Continuous Systems Market, By Region, 2018-2026 (USD Million)

Table 04. Others Market, By Region, 2018-2026 (USD Million)

Table 05. Global Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026 (USD Million)

Table 06. Final Drug Product Manufacturing Market, By Region, 2018-2026 (USD Million)

Table 07. Api Manufacturing Market, By Region, 2018-2026 (USD Million)

Table 08. Global Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026 (USD Million)

Table 09. Pharmaceutical Continuous Manufacturing For Pharmaceutical Companies Market, By Region, 2018-2026 (USD Million)

Table 10. Pharmaceutical Continuous Manufacturing For Contract Manufacturing Organizations, By Region, 2018-2026 (USD Million)

Table 11. Pharmaceutical Continuous Manufacturing For Others, By Region, 2018-2026 (USD Million)

Table 12. Pharmaceutical Continuous Manufacturing Market Revenue, By Region, 2018-2026 (USD Million)

Table 13. North America Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 (USD Million)

Table 14. U.S. Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 15. U.S. Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 16. U.S. Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 17. Canada Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 18. Canada Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 19. Canada Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 20. Mexico Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 21. Mexico Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 22. Mexico Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 23. North America Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 24. North America Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 25. North America Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 26. Europe Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 (USD Million)

Table 27. Germany Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 28. Germany Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 29. Germany Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 30. France Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 31. France Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 32. France Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 33. Uk Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 34. Uk Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 35. Uk Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 36. Italy Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 37. Italy Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 38. Italy Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 39. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 40. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 41. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 42. Europe Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 43. Europe Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 44. Europe Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 45. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 (USD Million)

Table 46. Japan Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 47. Japan Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 48. Japan Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 49. China Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 50. China Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 51. China Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 52. India Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 53. India Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 54. India Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 55. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 56. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 57. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 58. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 59. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 60. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 61. Lamea Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 (USD Million)

Table 62. Brazil Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 63. Brazil Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 64. Brazil Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 65. South Africa Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 66. South Africa Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 67. South Africa Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 68. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 69. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 70. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 71. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 72. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 73. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 74. Lamea Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 75. Lamea Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 76. Lamea Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 77. Coperion: Company Snapshot

Table 78. Coperion: Business Segment

Table 79. Gea Group: Company Snapshot

Table 80. Gea Group: Operating Segments

Table 81. Gea Group: Product Portfolio

Table 82. Lodige: Company Snapshot

Table 83. Lodige: Operating Segments

Table 84. Lodige: Product Portfolio

Table 85. Glatt: Company Snapshot

Table 86. Glatt: Operating Segments

Table 87. Glatt: Product Portfolio

Table 88. Hosokawa: Company Snapshot

Table 89. Hosokawa: Product Portfolio

Table 90. Korsch: Company Snapshot

Table 91. Korsch: Operating Segments

Table 92. Korsch: Product Portfolio

Table 93. L.B. Bohle: Company Snapshot

Table 94. L.B. Bohle: Operating Segments

Table 95. Munson: Company Snapshot

Table 96. L.B. Bohle: Operating Product Segments

Table 97. Munson: Product Portfolio

Table 98. Bosch Group: Company Snapshot

Table 99. Bosch Group: Operating Segments

Table 100. Bosch Group: Product Portfolio

Table 101. Thermo Fisher Scientific: Company Snapshot

Table 102. Thermo Fisher Scientific: Operating Segments

Table 103. Thermo Fisher Scientific: Product Portfolio

Licence Rights

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Bosch Packaging Technology, Coperion GmbH, GEA Group AG, Gebruder Lodige Maschinenbau GmbH, Glatt GmbH, Hosokawa Micron Corporation, Korsch AG, L.B. Bohle Maschinen + Verfahren GmbH, Munson Machinery Company, Inc., and Thermo Fisher Scientific Inc.

Company Profile

Company Profile Title

The global pharmaceutical continuous manufacturing market was valued at USD 393 million in 2018, and is projected to reach USD 855 million by 2026, registering a CAGR of 10.2% from 2019 to 2026.

Continuous manufacturing is advanced manufacturing approach that is performed by employing end-to-end integration of manufacturing subprocesses with a significant level of control strategies.

The growth of the global pharmaceutical continuous manufacturing market is anticipated to be driven by increase in adoption of continuous manufacturing systems over existing drug manufacturing process, technological advancements in CM systems, and rise in awareness of continuous manufacturing systems in developing regions are anticipated to significantly boost the growth of the pharmaceutical continuous manufacturing market during the forecast period. Continuous pharmaceutical manufacturing system offers advantages such as reduced fluctuation in production, improved yields, lower cost of operation & equipment further augment the market growth.

Moreover, initiatives taken by the Food and drug Administration (FDA) for promoting the use of pharmaceutical continuous manufacturing systems and advantage of CM systems over the batch manufacturing are the major factors to boost the growth of pharmaceutical continuous manufacturing market. However, higher cost of pharmaceutical continuous manufacturing systems impede the market growth.

Moreover, the CM process is more time-efficient, reduces energy needs, helps to increase productivity, and minimizes overall waste, which are expected to offer lucrative opportunity for the pharmaceutical continuous manufacturing market during the forecast period.

The global pharmaceutical continuous manufacturing market is segmented into product, application, end user, and region. On the basis of product, the market is classified into integrated continuous systems, semicontinuous systems, and control & software. By application, it is divided into final drug product manufacturing and API manufacturing. Depending on end user, it is categorized into pharmaceutical companies, contract manufacturing organizations, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of four major regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Product

o Integrated Continuous Systems

o Semicontinuous Systems

o Control & Software

Application Type

o Final Drug Product Manufacturing

o API Manufacturing

End User

o Pharmaceutical Companies

o Contract Manufacturing Organizations

o Others

By Region

North America

o U.S.

o Canada

o Mexico

Europe

o Germany

o France

o UK

o Italy

o Rest of Europe

Asia-Pacific

o Japan

o China

o India

o Rest of Asia-Pacific

LAMEA

o Brazil

o Saudi Arabia

o South Africa

o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Bosch Packaging Technology

Coperion GmbH

GEA Group AG

Gebruder Lodige Maschinenbau GmbH

Glatt GmbH

Hosokawa Micron Corporation

Korsch AG

L.B. Bohle Maschinen + Verfahren GmbH

Munson Machinery Company, Inc.

Thermo Fisher Scientific Inc.

READ MORE

Scope

Chapter 1: Introduction

1.1. Report Description

1.2. Key Benefits For Stakeholders

1.3. Key Market Segments

1.3.1. List of Key Players Profiled In The Report

1.4. Research Methodology

1.4.1. Secondary Research

1.4.2. Primary Research

1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

2.1. Key Findings of The Study

2.2. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope

3.2. Key Findings

3.2.1. Top Investment Pockets

3.2.2. Market Player Positioning, 2018

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Increase In Government Support For Continuous Manufacturing Adoption

3.3.1.2. Advantages offered By Continuous Manufacturing Systems

3.3.1.3. Surge In Adoption of Pharmaceutical Continuous Manufacturing Systems

3.3.2. Restraint

3.3.2.1. Poor Demand In Under Developed Countries

3.3.3. Opportunities

3.3.3.1. Growth Opportunities In Emerging Markets

3.3.4. Impact Analysis

Chapter 4: Pharmaceutical Continuous Manufacturing Market, By Product

4.1. Overview

4.1.1. Market Size And Forecast

4.2. Integrated Continuous Systems

4.2.1. Key Market Trends And Opportunities

4.2.2. Market Size And Forecast, By Region

4.2.3. Market Analysis, By Country

4.3. Semi-Continuous Systems

4.3.1. Key Market Trends And Opportunities

4.3.2. Market Size And Forecast, By Region

4.3.3. Market Analysis, By Country

4.4. Control & Software

4.4.1. Key Market Trends And Opportunities

4.4.2. Market Size And Forecast, By Region

4.4.3. Market Analysis, By Country

Chapter 5: Pharmaceutical Continuous Manufacturing Market, By Application

5.1. Overview

5.1.1. Market Size And Forecast

5.2. Final Drug Product Manufacturing

5.2.1. Market Size And Forecast

5.2.2. Market Analysis, By Country

5.3. Api Manufacturing

5.3.1. Market Size And Forecast

5.3.2. Market Analysis, By Country

Chapter 6: Pharmaceutical Continuous Manufacturing Market, By End User

6.1. Overview

6.1.1. Market Size And Forecast

6.2. Pharmaceutical Companies

6.2.1. Market Size And Forecast

6.2.2. Market Analysis, By Country

6.3. Contract Manufacturing Organizations

6.3.1. Market Size And Forecast

6.3.2. Market Analysis, By Country

6.4. Others

6.4.1. Market Size And Forecast

6.4.2. Market Analysis, By Country

Chapter 7: Pharmaceutical Continuous Manufacturing Market, By Region

7.1. Overview

7.1.1. Market Size And Forecast

7.2. North America

7.2.1. Key Market Trends, Growth Factors, And Opportunities

7.2.2. Market Size And Forecast, By Country

7.2.2.1. U.S.

7.2.2.1.1. U.S. Pharmaceutical Continuous Manufacturing Market, By Product

7.2.2.1.2. U.S. Pharmaceutical Continuous Manufacturing Market, By Application

7.2.2.1.3. U.S. Pharmaceutical Continuous Manufacturing Market, By End User

7.2.2.2. Canada

7.2.2.2.1. Canada Pharmaceutical Continuous Manufacturing Market, By Product

7.2.2.2.2. Canada Pharmaceutical Continuous Manufacturing Market, By Application

7.2.2.2.3. Canada Pharmaceutical Continuous Manufacturing Market, By End User

7.2.2.3. Mexico

7.2.2.3.1. Mexico Pharmaceutical Continuous Manufacturing Market, By Product

7.2.2.3.2. Mexico Pharmaceutical Continuous Manufacturing Market, By Application

7.2.2.3.3. Mexico Pharmaceutical Continuous Manufacturing Market, By End User

7.2.3. North America Market Size And Forecast, By Product

7.2.4. North America Market Size And Forecast, By Application

7.2.5. North America Market Size And Forecast, By End User

7.3. Europe

7.3.1. Key Market Trends, Growth Factors, And Opportunities

7.3.2. Market Size And Forecast, By Country

7.3.2.1. Germany

7.3.2.1.1. Germany Pharmaceutical Continuous Manufacturing Market, By Product

7.3.2.1.2. Germany Pharmaceutical Continuous Manufacturing Market, By Application

7.3.2.1.3. Germany Pharmaceutical Continuous Manufacturing Market, By End User

7.3.2.2. France

7.3.2.2.1. France Pharmaceutical Continuous Manufacturing Market, By Product

7.3.2.2.2. France Pharmaceutical Continuous Manufacturing Market, By Application

7.3.2.2.3. France Pharmaceutical Continuous Manufacturing Market, By End User

7.3.2.3. Uk

7.3.2.3.1. Uk Pharmaceutical Continuous Manufacturing Market, By Product

7.3.2.3.2. Uk Pharmaceutical Continuous Manufacturing Market, By Application

7.3.2.3.3. Uk Pharmaceutical Continuous Manufacturing Market, By End User

7.3.2.4. Italy

7.3.2.4.1. Italy Pharmaceutical Continuous Manufacturing Market, By Product

7.3.2.4.2. Italy Pharmaceutical Continuous Manufacturing Market, By Application

7.3.2.4.3. Italy Pharmaceutical Continuous Manufacturing Market, By End User

7.3.2.5. Rest of Europe

7.3.2.5.1. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Product

7.3.2.5.2. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Application

7.3.2.5.3. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By End User

7.3.3. Europe Market Size And Forecast, By Product

7.3.4. Europe Market Size And Forecast, By Application

7.3.5. Europe Market Size And Forecast, By End User

7.4. Asia-Pacific

7.4.1. Key Market Trends, Growth Factors, And Opportunities

7.4.2. Market Size And Forecast, By Country

7.4.2.1. Japan

7.4.2.1.1. Japan Pharmaceutical Continuous Manufacturing Market, By Product

7.4.2.1.2. Japan Pharmaceutical Continuous Manufacturing Market, By Application

7.4.2.1.3. Japan Pharmaceutical Continuous Manufacturing Market, By End User

7.4.2.2. China

7.4.2.2.1. China Pharmaceutical Continuous Manufacturing Market, By Product

7.4.2.2.2. China Pharmaceutical Continuous Manufacturing Market, By Application

7.4.2.2.3. China Pharmaceutical Continuous Manufacturing Market, By End User

7.4.2.3. India

7.4.2.3.1. India Pharmaceutical Continuous Manufacturing Market, By Product

7.4.2.3.2. India Pharmaceutical Continuous Manufacturing Market, By Application

7.4.2.3.3. India Pharmaceutical Continuous Manufacturing Market, By End User

7.4.2.4. Rest of Asia-Pacific

7.4.2.4.1. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product

7.4.2.4.2. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application

7.4.2.4.3. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User

7.4.3. Asia-Pacific Market Size And Forecast, By Product

7.4.4. Asia-Pacific Market Size And Forecast, By Application

7.4.5. Asia-Pacific Market Size And Forecast, By End User

7.5. Lamea

7.5.1. Key Market Trends, Growth Factors, And Opportunities

7.5.2. Market Size And Forecast, By Country

7.5.2.1. Brazil

7.5.2.1.1. Brazil Pharmaceutical Continuous Manufacturing Market, By Product

7.5.2.1.2. Brazil Pharmaceutical Continuous Manufacturing Market, By Application

7.5.2.1.3. Brazil Pharmaceutical Continuous Manufacturing Market, By End User

7.5.2.2. South Africa

7.5.2.2.1. South Africa Pharmaceutical Continuous Manufacturing Market, By Product

7.5.2.2.2. South Africa Pharmaceutical Continuous Manufacturing Market, By Application

7.5.2.2.3. South Africa Pharmaceutical Continuous Manufacturing Market, By End User

7.5.2.3. Saudi Arabia

7.5.2.3.1. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Product

7.5.2.3.2. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Application

7.5.2.3.3. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By End User

7.5.2.4. Rest of Lamea

7.5.2.4.1. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Product

7.5.2.4.2. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Application

7.5.2.4.3. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By End User

7.5.3. Lamea Market Size And Forecast, By Product

7.5.4. Lamea Market Size And Forecast, By Application

7.5.5. Lamea Market Size And Forecast, By End User

Chapter 8: Company Profiles

8.1. Coperion Gmbh

8.1.1. Company Overview

8.1.2. Company Snapshot

8.1.3. Operating Business Segments

8.1.4. Product Portfolio

8.1.5. Key Strategic Moves And Developments

8.2. Gea Group Ag

8.2.1. Company Overview

8.2.2. Company Snapshot

8.2.3. Operating Business Segments

8.2.4. Product Portfolio

8.2.5. Business Performance

8.3. Gebruder Lodige Maschinenbau Gmbh

8.3.1. Company Overview

8.3.2. Company Snapshot

8.3.3. Operating Business Segments

8.3.4. Product Portfolio

8.4. Glatt Gmbh

8.4.1. Company Overview

8.4.2. Company Snapshot

8.4.3. Operating Business Segments

8.4.4. Product Portfolio

8.5. Hosokawa Micron Corporation

8.5.1. Company Overview

8.5.2. Company Snapshot

8.5.3. Product Portfolio

8.5.4. Business Performance

8.6. Korsch Ag

8.6.1. Company Overview

8.6.2. Company Snapshot

8.6.3. Operating Business Segments

8.6.4. Product Portfolio

8.7. L.B. Bohle Maschinen + Verfahren Gmbh

8.7.1. Company Overview

8.7.2. Company Snapshot

8.7.3. Operating Business Segments

8.7.4. Product Portfolio

8.8. Munson Machinery Company, Inc.

8.8.1. Company Overview

8.8.2. Company Snapshot

8.8.3. Operating Business Segments

8.8.4. Product Portfolio

8.9. Robert Bosch Packaging Technology Gmbh

8.9.1. Company Overview

8.9.2. Company Snapshot

8.9.3. Operating Business Segments

8.9.4. Product Portfolio

8.9.5. Business Performance

8.10. Thermo Fisher Scientific, Inc.

8.10.1. Company Overview

8.10.2. Company Snapshot

8.10.3. Operating Business Segments

8.10.4. Product Portfolio

8.10.5. Business Performance


List Of Figure

List of Figures

Figure 01. Global Pharmaceutical Continuous Manufacturing Market Segmentation

Figure 02. Top Investment Pockets, 2018

Figure 03. Market Player Positioning, 2018

Figure 04. Impact Analysis

Figure 05. Comparative Analysis of Integrated Continuous Systems Market, By Country, 2018 & 2026 (USD Million)

Figure 06. Comparative Analysis of Semi-Continuous Systems Market, By Country, 2018 & 2026 (USD Million)

Figure 07. Comparative Analysis of Control & Software Market, By Country, 2018 & 2026 (USD Million)

Figure 08. Comparative Analysis of Final Drug Product Manufacturing Market, By Country, 2018 & 2026 (USD Million)

Figure 09. Comparative Analysis of Api Manufacturing Market, By Country, 2018 & 2026 (USD Million)

Figure 10. Comparative Analysis of Pharmaceutical Continuous Manufacturing For Pharmaceutical Companies Market, By Country, 2018 & 2026 (USD Million)

Figure 11. Comparative Analysis Pharmaceutical Continuous Manufacturing Market For Contract Manufacturing Organizations, By Country, 2018 & 2026 (%)

Figure 12. Comparative Analysis of Pharmaceutical Continuous Manufacturing Market For Others, By Country, 2018 & 2026 (%)

Figure 13. Net Sales, 2016-2018 (USD Million)

Figure 14. Gea Group: Net Sales By Segment, 2018 (%)

Figure 15. Gea Group: Net Sales By Region, 2018 (%)

Figure 16. Net Sales, 2016-2018 (USD Million)

Figure 17. Hosokawa: Net Sales By Segment, 2018 (%)

Figure 18. Hosokawa: Net Sales By Geography, 2018 (%)

Figure 19. Net Sales, 2016-2018 (USD Million)

Figure 20. Bosch Group: Net Sales By Segment, 2018 (%)

Figure 21. Bosch Group: Net Sales By Revenue, 2018 (%)

Figure 22. Thermo Fisher Scientific: Revenue, 2016-2018 (USD Million)

Figure 23. Thermo Fisher Scientific: Revenue Share, By Segment, 2018 (%)

Figure 24. Thermo Fisher Scientific: Revenue Share, By Region, 2018 (%)


List Of Table

List of Tables

Table 01. Global Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026 (USD Million)

Table 02. Integrated Continuous Systems Market, By Region, 2018-2026 (USD Million)

Table 03. Semi-Continuous Systems Market, By Region, 2018-2026 (USD Million)

Table 04. Others Market, By Region, 2018-2026 (USD Million)

Table 05. Global Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026 (USD Million)

Table 06. Final Drug Product Manufacturing Market, By Region, 2018-2026 (USD Million)

Table 07. Api Manufacturing Market, By Region, 2018-2026 (USD Million)

Table 08. Global Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026 (USD Million)

Table 09. Pharmaceutical Continuous Manufacturing For Pharmaceutical Companies Market, By Region, 2018-2026 (USD Million)

Table 10. Pharmaceutical Continuous Manufacturing For Contract Manufacturing Organizations, By Region, 2018-2026 (USD Million)

Table 11. Pharmaceutical Continuous Manufacturing For Others, By Region, 2018-2026 (USD Million)

Table 12. Pharmaceutical Continuous Manufacturing Market Revenue, By Region, 2018-2026 (USD Million)

Table 13. North America Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 (USD Million)

Table 14. U.S. Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 15. U.S. Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 16. U.S. Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 17. Canada Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 18. Canada Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 19. Canada Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 20. Mexico Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 21. Mexico Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 22. Mexico Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 23. North America Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 24. North America Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 25. North America Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 26. Europe Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 (USD Million)

Table 27. Germany Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 28. Germany Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 29. Germany Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 30. France Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 31. France Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 32. France Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 33. Uk Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 34. Uk Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 35. Uk Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 36. Italy Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 37. Italy Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 38. Italy Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 39. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 40. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 41. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 42. Europe Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 43. Europe Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 44. Europe Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 45. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 (USD Million)

Table 46. Japan Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 47. Japan Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 48. Japan Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 49. China Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 50. China Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 51. China Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 52. India Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 53. India Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 54. India Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 55. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 56. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 57. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 58. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 59. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 60. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 61. Lamea Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 (USD Million)

Table 62. Brazil Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 63. Brazil Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 64. Brazil Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 65. South Africa Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 66. South Africa Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 67. South Africa Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 68. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 69. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 70. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 71. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 72. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 73. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 74. Lamea Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 75. Lamea Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 76. Lamea Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 77. Coperion: Company Snapshot

Table 78. Coperion: Business Segment

Table 79. Gea Group: Company Snapshot

Table 80. Gea Group: Operating Segments

Table 81. Gea Group: Product Portfolio

Table 82. Lodige: Company Snapshot

Table 83. Lodige: Operating Segments

Table 84. Lodige: Product Portfolio

Table 85. Glatt: Company Snapshot

Table 86. Glatt: Operating Segments

Table 87. Glatt: Product Portfolio

Table 88. Hosokawa: Company Snapshot

Table 89. Hosokawa: Product Portfolio

Table 90. Korsch: Company Snapshot

Table 91. Korsch: Operating Segments

Table 92. Korsch: Product Portfolio

Table 93. L.B. Bohle: Company Snapshot

Table 94. L.B. Bohle: Operating Segments

Table 95. Munson: Company Snapshot

Table 96. L.B. Bohle: Operating Product Segments

Table 97. Munson: Product Portfolio

Table 98. Bosch Group: Company Snapshot

Table 99. Bosch Group: Operating Segments

Table 100. Bosch Group: Product Portfolio

Table 101. Thermo Fisher Scientific: Company Snapshot

Table 102. Thermo Fisher Scientific: Operating Segments

Table 103. Thermo Fisher Scientific: Product Portfolio

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Bosch Packaging Technology, Coperion GmbH, GEA Group AG, Gebruder Lodige Maschinenbau GmbH, Glatt GmbH, Hosokawa Micron Corporation, Korsch AG, L.B. Bohle Maschinen + Verfahren GmbH, Munson Machinery Company, Inc., and Thermo Fisher Scientific Inc.